Andrews Ravi, Samad Mohammed Sajid Abdul, Chimtalapudi Teja, Ramesh Venkat, Ali Muna Ather
Department of Nephrology, Apollo Health City, Hyderabad, India.
Department of Infectious Diseases, Apollo Health City, Hyderabad, India.
Indian J Nephrol. 2025 Jan-Feb;35(1):101-103. doi: 10.25259/ijn_507_23. Epub 2024 Jun 29.
Solid organ transplant (SOT) recipients are at increased risk of infective diarrheas. In such patients, diarrhea can be complicated by dehydration, leading to acute kidney injury or vascular thrombosis. Viral diarrhea in SOT is reported to be commonly due to cytomegalovirus and norovirus. As sapovirus is not routinely included in diagnostic evaluations, its epidemiology and natural history is not well documented. Anecdotal cases of sapovirus-associated diarrhea in renal transplant recipients have been treated with oral nitazoxanide, often with simultaneous reduction in immunosuppressants. We report sapovirus-associated diarrhea in a renal transplant recipient which responded well within two days to oral nitazoxanide. This, possibly, is the first such report from the Indian subcontinent of adequate control of sapovirus-associated diarrhea without any alteration in the immunosuppressant medications.
实体器官移植(SOT)受者发生感染性腹泻的风险增加。在这类患者中,腹泻可能并发脱水,导致急性肾损伤或血管血栓形成。据报道,SOT中的病毒性腹泻通常由巨细胞病毒和诺如病毒引起。由于在诊断评估中通常不常规检测札幌病毒,其流行病学和自然史尚无充分记录。肾移植受者中与札幌病毒相关的腹泻的个别病例已采用口服硝唑尼特治疗,通常同时减少免疫抑制剂用量。我们报告了1例肾移植受者发生的与札幌病毒相关的腹泻,口服硝唑尼特后两天内反应良好。这可能是印度次大陆第一份在不改变免疫抑制药物的情况下充分控制与札幌病毒相关腹泻的此类报告。